The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Is there an interaction between epidermal growth factor receptor (EGFR) inhibition and p16-status in patients (pts) with oropharyngeal squamous cell cancer: A retrospective analysis.
Tobenna Igewonu Nwizu
No relevant relationships to disclose
Lisa A. Rybicki
No relevant relationships to disclose
Deborah Chute
No relevant relationships to disclose
Cristina P. Rodriguez
No relevant relationships to disclose
Shlomo A. Koyfman
No relevant relationships to disclose
John Greskovich
No relevant relationships to disclose
Jerrold P. Saxton
No relevant relationships to disclose
Joseph Scharpf
No relevant relationships to disclose
Robert Lorenz
No relevant relationships to disclose
Brian Burkey
No relevant relationships to disclose
Benjamin J. Wood
No relevant relationships to disclose
Mumtaz Khan
No relevant relationships to disclose
Samer Al-khudari
No relevant relationships to disclose
Aaron P. Hoschar
No relevant relationships to disclose
Denise I. Ives
No relevant relationships to disclose
Joanna Bodmann
No relevant relationships to disclose
David J. Adelstein
Research Funding - AstraZeneca